https://synapse.patsnap.com/drug/45190af050df4f848abeee6a1ceae161
PLD-104 - Drug Targets, Indications, Patents - Synapse
drug targetspldindicationspatentssynapse
https://synapse.patsnap.com/drug/b64a01c1e8f749c78743d4d129a975a7
Liraglutide biosimilar (Zhongmei Huadong) - Drug Targets, Indications, Patents - Synapse
Liraglutide biosimilar (Zhongmei Huadong): a GLP-1R agonists Drug, Initially developed by Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd., Now, its global...
drug targetsliraglutidebiosimilarindicationspatents
https://synapse.patsnap.com/drug/b364814317f54aeab3af3977e1e59bc6
DC-TEADin1072 - Drug Targets, Indications, Patents - Synapse
drug targetsdcindicationspatentssynapse
https://synapse.patsnap.com/drug/a723adc82413489085a2ad7773afa392
Propentofylline - Drug Targets, Indications, Patents - Synapse
drug targetspropentofyllineindicationspatentssynapse
https://synapse.patsnap.com/drug/da694363141f3687baeb941175a80a32
WO2023168240 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/580a2f3f4f184db999bff415703d0ea6
COVID-2019 vaccine (Biological E.) - Drug Targets, Indications, Patents - Synapse
COVID-2019 vaccine (Biological E.): a SARS-CoV-2 S protein inhibitors Drug, Initially developed by Texas Children's Hospital Center for Vaccine Development,...
drug targetscovidvaccinebiologicalindications
https://synapse.patsnap.com/drug/3932456adde04b15aa837082c677fec2
HW-130 - Drug Targets, Indications, Patents - Synapse
drug targetshwindicationspatentssynapse
https://synapse.patsnap.com/drug/3c9c628896934707b7cf92afe49141a8
Ladirubicin - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://drugtargets.cambridgeinnovationinstitute.com/
Drug Targets Series - Cambridge Innovation Institute
drug targetsseriescambridgeinnovationinstitute
https://synapse.patsnap.com/drug/321a235175e548afa0eb7de40a21157f
TB-620R - Drug Targets, Indications, Patents - Synapse
drug targetstbindicationspatentssynapse
https://synapse.patsnap.com/drug/42c22f591353453fbbdd41515502c3f8
NMI-1182 - Drug Targets, Indications, Patents - Synapse
drug targetsnmiindicationspatentssynapse
https://synapse.patsnap.com/drug/4730dbf953dc4eaa8dc8fbad255e90b6
Bupropion Hydrochloride/Dextromethorphan - Drug Targets, Indications, Patents - Synapse
Bupropion Hydrochloride/Dextromethorphan: a CYP2D6 inhibitors, Dopamine reuptake inhibitors, NMDA receptor antagonists Drug, Initially developed by Antecip...
drug targetsbupropionhydrochloridedextromethorphanindications
https://hearingreview.com/hearing-loss/hearing-disorders/new-drug-targets-bone-disease-that-causes-hearing-loss
New Drug Targets Disease Sclerosteosis That Causes Hearing Loss | The Hearing Review
Jun 9, 2025 - The drug LGK974, which inhibits the Wnt signaling pathway, shows promise in reversing excessive bone growth in sclerosteosis.
new drughearing losstargetsdisease
https://ricerca.univaq.it/handle/11697/114722
Editorial: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer
editorial newdrug targets
https://synapse.patsnap.com/drug/2d0049410a9b4461885877fd6eead9ad
Setmelanotide Acetate - Drug Targets, Indications, Patents - Synapse
drug targetssetmelanotideacetateindicationspatents
https://synapse.patsnap.com/drug/3763bba44812333f8fec8462de797318
US20250066330 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/d33c4352fe504f15a47d7a2da837a35d
NNC-26-0610 - Drug Targets, Indications, Patents - Synapse
drug targetsnncindicationspatentssynapse
https://synapse.patsnap.com/drug/37daebe83f3a4343ba021545962c495e
Glimepiride/Vildagliptin/Metformin Hydrochloride - Drug Targets, Indications, Patents - Synapse
Glimepiride/Vildagliptin/Metformin Hydrochloride: a DPP-4 inhibitors, PRKAB1 activators, SUR1 inhibitors Drug, Initially developed by Laboratorios Silanes SA...
metformin hydrochloridedrug targetsglimepiridevildagliptinindications
https://synapse.patsnap.com/drug/46dcf1f7af7a33f3b3f98b5d842b85a5
WO2024110405 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/41afddd1f2b14bc283e24fe78e48709d
MF-094 - Drug Targets, Indications, Patents - Synapse
drug targetsmfindicationspatentssynapse
https://synapse.patsnap.com/drug/3fd5bb7379644a3dbca53d6d4271cdb5
MT-5594 - Drug Targets, Indications, Patents - Synapse
drug targetsmtindicationspatentssynapse
https://synapse.patsnap.com/drug/5268a82b6c72430880a696b2894f5e86
Dengue/Zika/ West-Nile (Protinhi) - Drug Targets, Indications, Patents - Synapse
west niledrug targetsdenguezikaindications
https://synapse.patsnap.com/drug/33802cd753a64a53966cab4db1513510
[18F]NMeFAMP - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/4ee5bfe6bc2e395aa31f261a7534cdfb
WO2022212496 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/b40496bd034645bd918c40e85d475072
Izastobart - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://www.innovations-report.com/health-life/health-and-medicine/report-9916/
New Drug Targets Blood Protein for Alzheimer's and Diabetes - Innovations Report
May 16, 2002 - Scientists at UCL have developed a drug to treat a serious medical condition linked to Alzheimer`s disease and type 2 diabetes. The research, supported by the...
new drugblood protein
https://synapse.patsnap.com/drug/397a987600963ff59c1ad91b6dc54bbb
CN116077448 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/56315e54b280409a95366e6161e9f55f
Xiaoer Qingfei Heji (mixture) - Drug Targets, Indications, Patents - Synapse
drug targetsmixtureindicationspatentssynapse
https://synapse.patsnap.com/drug/56d3f4ff51de3bf7a101c73b7304e248
CN114369581 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://eprints.lancs.ac.uk/id/eprint/56720/?template=browse
Autophagy in parasitic protists: unique features and drug targets - Lancaster EPrints
unique featuresdrug targetsautophagyparasiticprotists
https://synapse.patsnap.com/drug/3d124d532e7d4e4cb608f881c0f73a63
Clopidogrel Bisulfate/Omeprazole - Drug Targets, Indications, Patents - Synapse
Clopidogrel Bisulfate/Omeprazole: a P2Y12 receptor antagonists, Platelet-activating factor inhibitors, Proton pump inhibitors Drug, Initially developed by...
clopidogrel bisulfatedrug targetsomeprazoleindicationspatents
https://synapse.patsnap.com/drug/360110b8454b36cc9451defb5f0fe142
WO2024214046 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/3984868a28e64375bde4273502adb4ad
S-37245 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/a4bc8165b321419eb916795d4b5bb3ef
CJRB-304 - Drug Targets, Indications, Patents - Synapse
drug targetscjrbindicationspatentssynapse
https://synapse.patsnap.com/drug/44f928ef790946c2ada6741299f8b8e4
iRucaparib-AP5 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/3cd5d4534f7a4489bfb645e9ede0d7dd
TAA (Bioheng Biotech) - Drug Targets, Indications, Patents - Synapse
drug targetstaabiotechindicationspatents
https://synapse.patsnap.com/drug/389ed78df23e45f58ea0a6246cadbbbe
IVIG(Rockefeller University) - Drug Targets, Indications, Patents - Synapse
rockefeller universitydrug targetsivigindicationspatents
https://synapse.patsnap.com/drug/43e47e8e895b4d71afa9b8d1d075b471
IL-2-So-Lipo - Drug Targets, Indications, Patents - Synapse
drug targetsillipoindicationspatents
https://synapse.patsnap.com/drug/3febbceb5cab4690811cad2e4188bf5e
Inflammation Target(Negative Allosteric Modulator)(septerna) - Drug Targets, Indications, Patents -...
drug targetsinflammationnegativemodulatorindications
https://synapse.patsnap.com/drug/e33859e9df2e490c9f536afce3b4f6f2
RP-116474 - Drug Targets, Indications, Patents - Synapse
drug targetsrpindicationspatentssynapse
https://synapse.patsnap.com/drug/d6db78296fc9443bbd98abd773623ef9
Diiodothyropropionic Acid - Drug Targets, Indications, Patents - Synapse
drug targetsacidindicationspatentssynapse
https://synapse.patsnap.com/drug/567d85fd12b54f1ea9fb88ac70eff025
CTV-05 - Drug Targets, Indications, Patents - Synapse
drug targetsctvindicationspatentssynapse
https://synapse.patsnap.com/drug/4b495200eeea4459bceb1d3d4d61d074
ONC-841 - Drug Targets, Indications, Patents - Synapse
drug targetsoncindicationspatentssynapse
https://synapse.patsnap.com/drug/aa295b15aa544da8ba03b25133955613
Adenoviral brachyury vaccine(Etubics Corp.) - Drug Targets, Indications, Patents - Synapse
drug targetsbrachyuryvaccinecorpindications
https://synapse.patsnap.com/drug/36b69a49b8fb433abc3a44c0fafd2163
SynOV 4 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/53e1005ebf05473ca7e1b07b9243e047
L-671329 - Drug Targets, Indications, Patents - Synapse
drug targetslindicationspatentssynapse
https://synapse.patsnap.com/drug/4ae4b56ee1084297aa2f97edfaf3056d
HRS-5346 - Drug Targets, Indications, Patents - Synapse
drug targetshrsindicationspatentssynapse
https://synapse.patsnap.com/drug/50988c0f58634d20944440cec8ab8a10
RO-84304 - Drug Targets, Indications, Patents - Synapse
drug targetsroindicationspatentssynapse
https://synapse.patsnap.com/drug/526821b6b69444ed9d1747270e9738d5
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline - Drug Targets, Indications, Patents -...
Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline: a DPP-4 inhibitors, SGLT2 inhibitors Drug, Initially developed by Astellas Pharma, Inc., Now, its...
sitagliptin phosphatedrug targetsmonohydrateipragliflozinproline
https://synapse.patsnap.com/drug/ab2df9be048049d9b1c3fedc465fc53a
ReS18-H - Drug Targets, Indications, Patents - Synapse
drug targetshindicationspatentssynapse
https://synapse.patsnap.com/drug/8849a6ac3994313585a12d3521ee2147
CN116688125 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/3bdef575dd6a4e51b498bd6abc6654a6
Kinase inhibitors(Califia/URMC) - Drug Targets, Indications, Patents - Synapse
drug targetskinaseinhibitorsurmcindications
https://synapse.patsnap.com/drug/d3a92a0496a34c57867effafcf302778
TT19 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/9ce921f7f59044e983228c76c5ab1b81
CAR-iPSC-Treg - Drug Targets, Indications, Patents - Synapse
drug targetscaripsctregindications
https://synapse.patsnap.com/drug/08b771b505133e9db33a5a548c73bb85
CN114957222 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/3a1ec3c04a44363ab5e2b9c42eff2722
WO2024238942 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/32bd571d46244354baaa6ed5d07197dc
SKP-0162 - Drug Targets, Indications, Patents - Synapse
drug targetsskpindicationspatentssynapse
https://synapse.patsnap.com/drug/6a916355fbdb42139db264e3162fbdf4
Ocankitug - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://www.progress.org.uk/genome-study-reveals-potential-drug-targets-for-colon-cancer/
Genome study reveals potential drug targets for colon cancer | PET
Oct 23, 2025 - The genetic mutations underlying colon and rectal cancer are so similar that these cancers should be classified as one disease, a study suggests. Researchers...
drug targetscolon cancergenomestudyreveals
https://synapse.patsnap.com/drug/3861009f394f4177837f81519c13dea3
Sulfadiazine/Trimethoprim - Drug Targets, Indications, Patents - Synapse
drug targetssulfadiazinetrimethoprimindicationspatents
https://dailydose.ttuhsc.edu/2023/june/research-collaboration-Leishmaniasis.aspx
TTUHSC-TTU Research Collaboration Leads to Possible Drug Targets for Leishmaniasis
research collaborationdrug targetsttuleads
https://synapse.patsnap.com/drug/57fbd310a471491fb63e7b1b3d61291d
LAVA-1266 - Drug Targets, Indications, Patents - Synapse
drug targetslavaindicationspatentssynapse
https://synapse.patsnap.com/drug/3a3c2a2dc9034b0382acd30790360d38
Kanglexin - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://gbwebhosting.com/article/revolutionary-drug-targets-p53-gene-mutation-in-cancer-treatment
Revolutionary Drug Targets P53 Gene Mutation in Cancer Treatment (2026)
May 17, 2026 - The recent study on targeting the elusive P53 gene mutation in cancer treatment is a groundbreaking development with far-reaching implications. While the P53...
drug targetsgene mutationcancer treatmentrevolutionary
https://synapse.patsnap.com/drug/d4d0297b4efe4c87bbf28436a51694e9
Recombinant Zoster Vaccine (CHO cell) (Jianda Biomedical) - Drug Targets, Indications, Patents -...
Recombinant Zoster Vaccine (CHO cell) (Jianda Biomedical): a Immunostimulants Drug, Initially developed by Jianda Biomedical (Nanjing) Co., Ltd., Now, its...
drug targetsrecombinantzostervaccinecho
https://synapse.patsnap.com/drug/d3ff2012b1834d3b89b4f3add5bdf612
Ornidazole - Drug Targets, Indications, Patents - Synapse
drug targetsornidazoleindicationspatentssynapse
https://synapse.patsnap.com/drug/433077e03b124df7928d8e2c78ccecba
ChangTai Keli - Drug Targets, Indications, Patents - Synapse
drug targetschangtaikeliindicationspatents
https://synapse.patsnap.com/drug/433001584d9b4d008af6a3e92378883d
68Ga-RMX-VH - Drug Targets, Indications, Patents - Synapse
drug targetsrmxvhindicationspatents
https://synapse.patsnap.com/drug/46f870855506992e45ae2bf790e82e43
HZ-R061 - Drug Targets, Indications, Patents - Synapse
drug targetshzindicationspatentssynapse
https://synapse.patsnap.com/drug/d853e6cb1d16451b97e030441c38fb7f
CU-2010 - Drug Targets, Indications, Patents - Synapse
drug targetscuindicationspatentssynapse
https://synapse.patsnap.com/drug/4aec1234232c4dd7b949adb1b5e77306
Imiloxan - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/adbd0c6184b54d069bd8a1de19f2f257
[11C]NNC-112 - Drug Targets, Indications, Patents - Synapse
drug targetsnncindicationspatentssynapse
https://synapse.patsnap.com/drug/e839db7730293c79ad7abe563f761476
CN118638233 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://www.pharmatutor.org/article/magazines/articles/july-2017/drug-targets-identification-of-mycobacterium-tuberculosis-by-metabolic-pathway-analysis-insilico-process
Drug targets identification of Mycobacterium tuberculosis by metabolic pathway analysis: insilico...
Mycobacterium tuberculosis is reputed to have the highest annual global mortality among all of the pathogens[1]. The rise in tuberculosis (TB) incidence over...
drug targetsmycobacterium tuberculosismetabolic pathwayidentification
https://www.cusabio.com/drug-targets/kidney-cancer.html
Drug Targets for Kidney Cancer Research- CUSABIO
drug targetskidney cancerresearchcusabio
https://synapse.patsnap.com/drug/3d7519e07d6d452191bf1152bc8d7ea0
MSI-99 - Drug Targets, Indications, Patents - Synapse
drug targetsmsiindicationspatentssynapse
https://synapse.patsnap.com/drug/48c8c6c0ea633441842575253cac5852
WO2025034606 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/521f773bd5f4312aa9c7e9b6397b9752
CN117736338 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/3922d2c281c25a9c5b4673e08b8b89b9
DAS-6-5-6-CRBN - Drug Targets, Indications, Patents - Synapse
drug targetsdascrbnindicationspatents
https://synapse.patsnap.com/drug/4cec1d2738294441a19d4aeb903cef3d
TRN-257 - Drug Targets, Indications, Patents - Synapse
drug targetstrnindicationspatentssynapse
https://www.benthamscience.com/journal/13/related-ebooks
Current Drug Targets | Bentham Science
Current Drug Targets aims to cover developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. receptors, enzymes, genes.
drug targetscurrentbenthamscience
https://synapse.patsnap.com/drug/ad0f3619a2363cf99dcace737ad87f1c
WO2023138621 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/dd9686f8f8f84deb99079c6974af5bdf
Compound 28(Vitas M Chemical) - Drug Targets, Indications, Patents - Synapse
drug targetscompoundvitaschemicalindications
https://synapse.patsnap.com/drug/3b6012ef7b6532d589bf31e10e6c8ab9
CN118852362 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/525ffb3ad0343d3295c840242b21b746
US20240409532 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/d3d1e88fbd3343e79628d76af5190161
89Zr-df-IAB46 - Drug Targets, Indications, Patents - Synapse
drug targetsdfindicationspatentssynapse
https://synapse.patsnap.com/drug/af47f82d84f24c4dac26daa8e4589640
PROTAC ALK Degrader 31(Shanghaitech University) - Drug Targets, Indications, Patents - Synapse
drug targetsprotacalkdegrader
https://synapse.patsnap.com/drug/d2de5e76951f4c5385bc9acd34dd2b6d
SIPI-8294 - Drug Targets, Indications, Patents - Synapse
SIPI-8294: a 50S subunit inhibitors, Bacterial top IV inhibitors Drug, Initially developed by Shanghai Institute of Pharmaceutical Industry, Now, its global...
drug targetssipiindicationspatentssynapse
https://synapse.patsnap.com/drug/47d7113083fc335aaea9859b194e57bf
US20220184081 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/3e38407908cc3b439ebddac4c1c739a4
CN113896794 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/371116a1bf193932ad3f771a6f940550
WO2023083192 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/a30cf6bad6ae4845b76a59b898ade8c6
OraPro-COVID-19(iosBio Ltd.) - Drug Targets, Indications, Patents - Synapse
drug targetsoraprocovidltdindications
https://synapse.patsnap.com/drug/e728df44d6314ce48ac6b9e662c8bddc
[123I]CC-1 - Drug Targets, Indications, Patents - Synapse
drug targetsccindicationspatentssynapse
https://synapse.patsnap.com/drug/bb99ef00556048b98cbce1ea9acc37b5
Rituximab biosimilar(Aryogen) - Drug Targets, Indications, Patents - Synapse
Rituximab biosimilar(Aryogen): a CD20 inhibitors, ADCC, CD20-directed cytolytic effects Drug, Initially developed by Aryogen Pharmed, Now, its global highest...
drug targetsrituximabbiosimilarindicationspatents
https://synapse.patsnap.com/drug/3c1f820eae554782b64866ffc286a667
FL116 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/1f780222c4714ad4aaad19b06a2e4a52
6-H2 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/4ecb866af6f33dae87da7aab05d36636
WO2023213182 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/5438484c610435b8997e1e24210a35fd
CA3221922 - Drug Targets, Indications, Patents - Synapse
drug targetsindicationspatentssynapse
https://synapse.patsnap.com/drug/51863326726a4f8ead1953f8f0bbf57a
RWJ 445167 prodrugs (Johnson & Johnson) - Drug Targets, Indications, Patents - Synapse
drug targetsrwjprodrugsjohnsonindications
https://synapse.patsnap.com/drug/e3c7068601a14c5f93d860bceef7188d
Mutant p53 reactivators(Northwestern University) - Drug Targets, Indications, Patents - Synapse
northwestern universitydrug targetsmutantindicationspatents